Anhui Huaheng Biotechnology Co.,Ltd.’s Net Profit Rose 112.6% in First Three Quarters of 2022

Anhui Huaheng Biotechnology Co.,Ltd. (安徽华恒生物科技股份有限公司) (688639.SH) reported a net profit of 217 million yuan in the first three quarters of 2022, up 112.6% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, up 58.4% year-on-year.

At the end of the reporting period, it had 1.8 billion yuan in total assets and 424.6 million yuan in total liabilities, with a liability-to-asset ratio of 23.7%.